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O B J E C T I V E S To determine normal limits for ascending and descending thoracic aorta diameters in a
large population of asymptomatic, low-risk adult subjects.
B A C KG ROUND Assessment of aortic size is possible from gated noncontrast computed tomography
(CT) scans obtained for coronary calcium measurements. However, normal limits for aortic size by these
studies have yet to be deﬁned.
METHOD S In 4,039 adult patients undergoing coronary artery calcium (CAC) scanning, systematic
measurements of the ascending and descending thoracic aorta diameters were made at the level of the
pulmonary artery bifurcation. Multiple linear regression analysis was used to detect risk factors
independently associated with ascending and descending thoracic aorta diameter and exclude subjects
with these parameters from the ﬁnal analysis. The ﬁnal analysis groups for ascending and descending
thoracic aorta included 2,952 and 1,931 subjects, respectively. Subjects were then regrouped by gender,
age, and body surface area (BSA) for ascending and descending aorta, separately, and for each group,
the mean, standard deviation, and upper normal limit were calculated for aortic diameter as well as for
the calculated cross-sectional aortic area. Also, linear regression models were used to create BSA versus
aortic diameter nomograms by age groups, and a formula for calculating predicted aortic size by age,
gender, and BSA was created.
R E S U L T S Age, BSA, gender, and hypertension were directly associated with thoracic aorta
dimensions. Additionally, diabetes was associated with ascending aorta diameter, and smoking was
associated with descending aorta diameter. The mean diameters for the ﬁnal analysis group were 33 
4 mm for the ascending and 24  3 mm for the descending thoracic aorta, respectively. The
corresponding upper limits of normal diameters were 41 and 30 mm, respectively.
CONC L U S I O N S Normal limits of ascending and descending aortic dimensions by noncontrast gated
cardiac CT have been deﬁned by age, gender, and BSA in a large, low-risk population of subjects undergoing
CAC scanning. (J Am Coll Cardiol Img 2008;1:200–9) © 2008 by the American College of Cardiology
Foundation
From the *Departments of Imaging (Division of Nuclear Medicine), Department of Medicine (Division of Cardiology), and
CSMC Burns & Allen Research Institute, Cedars-Sinai Medical Center, and the Department of Medicine, University of
California at Los Angeles, School of Medicine, Los Angeles, California; and †the Heart Disease Prevention Program, Division
of Cardiology, University of California, Irvine, California. This study was supported in part by a grant from The Eisner
Foundation, Los Angeles, California. Drs. Wolak and Gutstein are fellows of Save a Heart Foundation, Los Angeles,
California, and American Physicians Fellowship, Boston, Massachusetts. H. William Strauss, MD, acted as Guest Editor for
this paper.Manuscript received September 7, 2007; revised manuscript received November 14, 2007, accepted November 21, 2007.
T
c
p
a
X
p
n
t
e
a
s
a
“
d
o
L
f
M
d
t
f
T
f
e
r
M
W
4
c
w
2
C
r
r
[
u
-
p
m
e
C
B
D
o
e
t
m
s
p
d
u
p
r

s
S
c
m
m
t
F
w
d

o
b
u
t
i
c
i
h
e
C
p
e
(
e
c
c
(
l
t
D
Y
s
k
3
s
t
1
3
3
c
o
t
i
w
i
ardiography
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 2 , 2 0 0 8
M A R C H 2 0 0 8 : 2 0 0 – 9
Wolak et al.
Thoracic Aorta Measurements by Noncontrast Cardiac CT
201horacic aortic aneurysm is a common, po-
tentially lethal, but treatable disease, particu-
larly if detected before dissection or rupture.
Accurate assessment of aortic size is a key
omponent in this detection and in guiding thera-
eutic decisions. Multiple imaging modalities are
vailable for assessing the thoracic aorta, including
-ray angiography, transesophageal echocardiogra-
hy (TEE), computed tomography (CT), and mag-
etic resonance imaging (MRI). Although all of
hese modalities have diagnostic value, CT has
volved to be the mainstay of evaluation owing to its
ccuracy and reproducibility, as well as its speed,
implicity, and true 3-dimensional capabilities.
To distinguish the normal from the enlarged
orta, it is necessary to standardize the values of
normal” aortic dimensions. Due to fundamental
ifferences in the imaging techniques, normal limits
f thoracic aorta dimensions for CT are needed.
ittle has been published regarding normal limits
or thoracic aortic dimensions with CT (1–3).
oreover, to our knowledge, no publications to
ate have reported these limits with gated, noncon-
rast chest CT studies—the studies commonly used
or coronary artery calcium (CAC) scanning.
herefore, our aim was to determine normal limits
or ascending and descending thoracic aorta diam-
ters in a large population of asymptomatic, low-
isk adult subjects undergoing CAC scanning.
E T H O D S
e examined the noncontrast gated CT findings of
,387 patients, age 26 to 92 years, free of known
linical coronary heart disease (CHD), who under-
ent CAC scanning during the period from July
004 to March 2007 at Cedars-Sinai Medical
enter. Subjects were self-referred (n  44, 1%),
eferred by their physician (n  3,308, 75%), or
ecruited as part of ongoing research (EISNER
Early Identification of Subclinical Atherosclerosis
sing NoninvasivE Imaging Research]-1, -2, and
3) protocols (n  1,035, 24%). An additional 547
atients with incomplete data were excluded (e.g.,
issing height, missing weight, and/or aorta diam-
ter not measured). The study was approved by the
edars-Sinai Medical Center Institutional Review
oard.
ata collection. Information regarding the presence
f categorical cardiac risk factors was collected in
very patient through written questionnaires. Sys-
emic arterial hypertension was defined as a docu-
ented history of high blood pressure. Current omoking or history of smoking was defined as
ositive smoking status. Hypercholesterolemia was
efined according to the National Cholesterol Ed-
cation Program (4) guidelines: low-density li-
oprotein (LDL) 100 mg/dl and Framingham
isk score 20%, 2 or more risk factors and LDL
130 mg/dl, or LDL 160 mg/dl. All lipid mea-
urements were within 1 week of the CT study.
ubjects were classified as having diabetes if they
arried an established diagnosis of diabetes mellitus
ade by a physician and/or were receiving treat-
ent with insulin or oral hypoglycemic agents, or if
heir measured fasting glucose was 126 mg/dl.
amily history of coronary artery disease (CAD)
as defined as a CAD event occurring in a first-
egree relative (men age 65 years and women age
55 years). Weight and height were also
btained and body mass index (BMI) and
ody surface area (BSA) were calculated
sing the Mosteller (5) method. Among
he 4,387 subjects, 348 subjects with miss-
ng clinical data (56, 111, 269, and 277
ases of missing information about smok-
ng, diabetes mellitus, dyslipidemia, and
ypertension, respectively) were also
xcluded.
T imaging protocol. The CT studies were
erformed on 1 of 4 CT scanners: 2
lectron beam computed tomography
EBCT) scanners (GE Imatron, C-150 or
-Speed, GE Medical Systems, San Fran-
isco, California), a 16-slice multidetector
omputed tomography (MDCT) scanner
Brilliance CT scanner, Philips, Cleve-
and, Ohio), and a dual source computed
omography (DSCT) scanner (Somatom
efinition, Siemens, New York, New
ork). For EBCT, we used a protocol of 3-mm
lice thickness, 50- or 100-ms exposure time, 130
Vp, 630-mA tube current, either a 300- or
50-mm field of view for reconstruction, and a
harp reconstruction kernel. For MDCT, the pro-
ocol was 2.5-mm slice thickness, 140 kVp,
68-mA tube current, 250-ms exposure time, and a
50-mm field of view. For DSCT, the protocol was
-mm slice thickness, 140 kVp, 150-mA tube
urrent, 200-ms exposure time, and a 350-mm field
f view. Prospective electrocardiogram triggering at
he heart rate-dependent percentage of the R-R
nterval was used for all scanners. The CT images
ere acquired in the craniocaudal direction from
mmediately inferior to the aortic arch to the level
A B B
A N D
BMI
BSA
CAC
CAD
CHD
CT
DSCT
tomog
EBCT
comp
LDL
MDCT
comp
MRI
imagi
TEE
echocf the diaphragm in a single breath-hold fR E V I A T I O N S
A C R O N YM S
bodymass index
body surface area
coronary artery calcium
coronary artery disease
coronary heart disease
computed tomography
 dual source computed
raphy
 electron beam
uted tomography
low-density lipoprotein
multidetector
uted tomography
magnetic resonance
ng
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202xaminations. For interpretation, the images were
ransferred to a dedicated workstation (NetraMD,
cImage, Los Altos, California). Systematic mea-
urements of the outer aortic wall perpendicular to
he axis of rotation of the aorta (Fig. 1) in the axial
lane at the lower level of the pulmonary artery
ifurcation in both the ascending and descending
orta were made by a licensed radiology technician
xperienced in cardiac CT. Measurements in excess
f 3.5 cm were verified by an imaging cardiologist
D.S.B., J.D.F., L.E.J.T., or S.W.H.). Ascending
nd descending aorta cross-sectional areas were
alculated from the measured diameter and indexed
o BSA.
tatistical analysis. All continuous variables were
ssessed for normality using the Shapiro-Francia
est and assessed visually by inspection of histo-
rams and standardized normal probability (P-P)
lots. Continuous variables were compared using
he t test for 2 groups and categorical variables were
ompared using the Pearson chi-square statistic.
Using multiple linear regression analysis, we
ought to detect parameters that are associated with
scending and descending thoracic aorta size and to
xclude patients with these parameters from the
nal analysis groups; therefore, the final analysis
roup would include only patients without param-
ters that influence the aorta size and can be called
Thoracic Aorta Measurements
slice at the lower level of the pulmonary artery bifurcation from a
tomography coronary artery calcium scan in a patient with nor-
dimensions showing the method for deriving the ascending and
aortic dimensions. For interpretation, the images were trans-
dedicated workstation (NetraMD, ScImage, Los Altos, California).
arrows represent outer wall thoracic ascending aortic diameter
ic descending aortic diameter measurements perpendicular to the
tion of the aorta.ssentially “normalized.” We employed a 2-stage bodel. A main effects model, which included po-
entially clinically important predictors (i.e., age,
ender, smoking, family history of CHD, diabetes,
yslipidemia, and hypertension), was developed in
tage I and a main effects plus interactions model in
tage II. Separate models were developed for as-
ending and descending aorta. Although either
MI or BSA formulas can be used for body size,
SA was chosen as the adjusting body size variable
or all subsequent analyses. This is because BSA
as previously found to have a greater association
ith thoracic aortic diameter than BMI does (6,7),
nd BSA was the body size variable that entered
nto selection models most frequently.
Additionally, regression diagnostics (statistical
ethods used for quality assurance of regression
odels) (8), including checking the assumptions of
inear regression, analysis of residuals, checking for
ulticollinearity, model specification, and model
alidation using a jackknifing procedure, were used
o assess the stage I models. The most influential
utliers or high leverage subjects were thus identi-
ed and then excluded as part of the normalization
rocess.
Using the stage I models, all 2  2 interactions
ere tested for significance at the relaxed 0.10
lpha level, both singly and against their main
ffects. Additionally, the significant interaction
erms were tested against each other using stepwise
odel selection to produce the stage II models. All
otential interactions were investigated. Regression
iagnostics were done on stage II models, as de-
cribed for stage I. None of the predictors were
hown to be collinear, except when interaction
erms were introduced. Standardized regression co-
fficients were used to assess the relative contribu-
ion of the predictors in both stage I and II models.
ased on these analyses, we were able to identify
ingle predictors or interactions that had both
ignificant (p 0.05) and strong influence on aortic
ize (nonstandardized beta coefficient 0.5 in ab-
olute value, meaning either 0.5 mm or 0.5
m). Subjects with influential predictors or mani-
esting high leverage on the model’s diagnostics
ere later excluded from the final analysis group.
For the final analysis, we grouped the subjects by
ender, age, and BSA for the ascending and de-
cending aorta, separately. We calculated the mean
ortic diameter, standard deviation, and upper nor-
al limit (mean  2 standard deviations) for each
roup. We also used linear regression models to
reate BSA versus aortic diameter nomogramsFigure 1.
Transaxial
computed
mal aortic
descending
ferred to a
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and thorac
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203revious reports used aortic diameter and area
nconsistently, we also calculated aortic area. Fi-
ally, we created a formula for calculation of pre-
icted aortic size by age, gender, and BSA. The
pper limit of normal was chosen as 2 standard
eviations above the mean.
All data were analyzed using Stata version 8
StataCorp, College Station, Texas), Analyze It
ersion 1.7 (Analyse-it Software, Leeds, England),
nd SPSS version 12 (SPSS Inc., Chicago, Illinois).
E S U L T S
able 1 shows the clinical characteristics of the
opulation. Male patients were significantly differ-
nt from female patients in all parameters other
han prevalence of diabetes and hypertension.
Table 2 shows the stage I models of potential
linical predictors of aortic diameter for the ascend-
Table 1. Clinical Characteristics of the Initial Study Population
Overall
(n  4,039)
F
Age (yrs) 55.0 10.2
BSA (m2) 1.9 0.3
BMI (kg/m2) 26.4 4.7
Smoking 1,626 (40.3%)
Family history of CAD 1,443 (35.7%)
Diabetes 192 (4.8%)
Dyslipidemia 1,444 (35.8%)
Hypertension 1,083 (26.8%)
Ascending aorta (mm) 33.2 4.1
Descending aorta (mm) 24.6 3.0
BMI  body mass index; BSA  body surface area; CAD  coronary artery dise
Table 2. Stage I Models: Potentially Clinically Important Predict
Ascending Aorta
n  4,039
Adjusted R2  0.28
Predictor
Unstandardized
Coefﬁcient
(Standardized)
Standard
Error
Age 0.15 (0.38) 0.006
Male gender 1.18 (0.14) 0.15
BSA* 1.22 (0.30) 0.07
Smoking 0.05 (0.005) 0.11
Family history of CAD 0.09 (0.01) 0.11
Diabetes 0.65 (0.03) 0.26
Dyslipidemia 0.07 (0.008) 0.11
Hypertension 0.76 (0.08) 0.13
Constant 14.58 0.62
*Per 0.25 increments.
Abbreviations as in Table 1.ng and descending aorta, separately. Both models
ound that age, gender, BSA, diabetes, and hyper-
ension were significant predictors of aortic diame-
er. Smoking was an independent predictor only of
escending aortic diameter.
Stage II models (significant stage I variables 
nteractions) are presented in Table 3. For both the
scending and descending aorta, age, BSA, diabe-
es, hypertension, and an interaction between age
nd male gender were significant predictors of
ortic diameter. Interactions between BSA and
moking, BSA and hypertension, and hypertension
nd dyslipidemia were found to be exclusively asso-
iated with descending aortic diameter.
For the ascending aorta, hypertension and diabe-
es mellitus were found in stage II models to be
ignificant and influential parameters; therefore,
,225 subjects with hypertension and/or diabetes
ere excluded from the final analysis. For the de-
ale Patients
 1,529)
Male Patients
(n  2,510)
p
Value
7.5 9.7 53.5 10.2 0.0001
1.7 0.2 2.1 0.2 0.0001
5.1 5.3 27.2 4.2 0.0001
5 (42.2%) 981 (39.1%) 0.05
8 (39.8%) 835 (33.3%) 0.001
2 (5.4%) 110 (4.4%) 0.16
7 (31.2%) 967 (38.5%) 0.001
6 (25.9%) 687 (27.4%) 0.31
1.8 3.7 34.0 4.1 0.0001
3.0 2.6 25.6 2.8 0.0001
of Aortic Diameter
Descending Aorta
n  4,035
Adjusted R2  0.45
p
Value
Unstandardized
Coefﬁcient
(Standardized)
Standard
Error
p
Value
0.001 0.13 (0.44) 0.004 0.001
0.001 1.58 (0.26) 0.01 0.001
0.001 1.12 (0.38) 0.05 0.001
0.69 0.23 (0.04) 0.07 0.001
0.45 0.03 (0.005) 0.07 0.66
0.01 0.33 (0.02) 0.17 0.05
0.57 0.06 (0.01) 0.07 0.39
0.001 0.37 (0.06) 0.08 0.001
0.001 7.71 0.40 0.001em
(n
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204cending aorta, hypertension and smoking were sig-
ificant and influential parameters; therefore, 2,286
atients with hypertension and/or smoking were ex-
luded from the final analysis. We additionally ex-
luded 193 and 55 cases of outliers for the ascending
orta and descending aorta, respectively, after deter-
ining that they were influential and had high lever-
ge and, thus, were likely to be abnormal. The final
Table 3. Stage II Models: Stage I Models  Interactions
Ascending Aorta
(n  4,038)
Adjusted R2  0.2
Predictor
Unstandardized
Coefﬁcient
(Standardized)
Standar
Error
Age 0.13 (0.32) 0.009
Male gender 0.87 (0.10) 0.66
BSA* 1.23 (0.30) 0.07
Smoking† 0.03 (0.004) 0.11
Family history of CAD 0.09 (0.01) 0.11
Diabetes 0.66 (0.03) 0.26
Dyslipidemia 0.08 (0.01) 0.11
Hypertension 0.78 (0.09) 0.13
Age, male 0.04 (0.24) 0.01
BSA,† smoking — —
Hypertension,† BSA — —
Hypertension,† dyslipidemia — —
Constant 15.91 0.74
*Per 0.25 increments; †past or current smoking.
Abbreviations as in Table 1.
nd Descending Aortic Diameters by Gender, Age, and BSA
m2)
Ascending (mm)* (n  2,952)
Female Patients
(n  1,147)
Male Patients
(n  1,805)
70 28.4 2.7, 33.8 (22.6–39.8) 28.6 2.2, 33.0 (26.0–32.
1.89 30.0 2.2, 34.4 (26.0–34.2) 30.1 3.1, 36.3 (24.9–37.
2.09 29.8 2.6, 35.0 (26.7–35.6) 30.9 2.7, 36.3 (21.8–38.
.1 31.3, NA (31.3)† 32.3 3.0, 38.3 (25.6–41.
70 29.6 2.8, 35.2 (21.9–36.9) 31.0 3.8, 38.6 (26.0–36.
1.89 31.4 2.9, 37.2 (24.7–39.7) 31.7 3.2, 38.1 (21.9–39.
2.09 32.5 3.2, 38.9 (26.7–40.4) 33.1 3.3, 39.7 (26.7–41.
.1 34.4 3.1, 40.6 (29.4–39.0) 34.4 3.1, 40.6 (25.3–42.
70 31.1 2.9, 36.9 (24.6–39.1) 31.5 2.4, 36.3 (28.0–34.
1.89 31.8 2.6, 37.0 (26.5–37.6) 33.5 3.1, 39.7 (28.0–41.
2.09 33.0 3.0, 39.0 (26.7–40.3) 34.6 3.3, 41.2 (26.0–43.
.1 35.4 3.3, 42.0 (30.1–43.8) 36.1 3.5, 43.1 (28.0–52.
70 32.5 2.5, 37.5 (27.4–37.6) 33.9 2.3, 38.5 (32.2–37.
1.89 33.4 2.9, 39.2 (26.7–44.4) 35.0 3.0, 41.0 (28.7–42.
2.09 34.3 4.2, 42.7 (28.0–43.8) 35.8 3.2, 42.2 (28.7–43.
.1 32.8, NA (30.8–34.9)† 36.8 2.8, 42.4 (32.1–48.
ean 1 SD, upper limit (range). †In cases when there were fewer than 6 patients
1.nalysis groups included 2,952 subjects (1,147 female
nd 1,805 male subjects) and 1,931 subjects (736
emale and 1,195 male subjects) for the ascending and
escending aorta, respectively.
The mean aortic diameters for the final analysis
roup in the combined genders were 33  4 mm
nd 24  3 mm for ascending and descending
horacic aorta, respectively. The corresponding up-
Descending Aorta
(n  4,034)
Adjusted R2  0.45
p
Value
Unstandardized
Coefﬁcient
(Standardized)*
Standard
Error
p
Value
0.001 0.11 (0.39) 0.006 0.001
0.19 0.19 (0.03) 0.43 0.66
0.001 1.29 (0.43) 0.06 0.001
0.77 2.11 (0.35) 0.55 0.001
0.46 0.03 (0.004) 0.07 0.72
0.01 0.33 (0.02) 0.17 0.05
0.46 0.16 (0.03) 0.09 0.07
0.001 1.81 (0.27) 0.67 0.003
0.001 0.03 (0.22) 0.007 0.001
— 0.24 (0.31) 0.07 0.001
— 0.20 (0.24) 0.08 0.01
— 0.37 (0.04) 0.16 0.02
0.001 7.41 0.53 0.001
Descending (mm)* (n  1,931)
Female Patients
(n  736)
Male Patients
(n  1,195)
20.2 1.4, 23.0 (17.9–23.2) 20.9, NA (19.8–23.0)†
21.4 1.6, 24.6 (17.8–24.0) 22.6 2.0, 26.6 (18.6–27.4)
20.3 1.2, 22.7 (18.5–22.0) 23.3 1.7, 26.7 (18.5–26.8)
21.9, NA (21.9)† 24.3 2.0, 28.3 (20.3–30.1)†
21.1 1.6, 24.3 (17.1–24.6) 22.0 1.1, 24.2 (20.6–23.9)
22.2 1.6, 25.4 (19.1–26.1) 23.5 2.0, 27.5 (19.2–30.1)
23.6 1.8, 27.2 (19.8–26.0) 24.8 2.2, 29.2 (19.8–31.4)
23.9 2.2, 28.3 (21.0–29.4) 25.8 1.9, 29.6 (20.5–30.8)
22.3 1.8, 25.9 (18.5–27.4) 23.1 1.5, 26.1 (20.6–26.0)
23.3 1.9, 27.1 (19.8–27.4) 25.2 1.7, 28.6 (21.9–30.2)
24.0 1.9, 27.8 (20.5–28.0) 25.9 2.0, 29.9 (20.6–31.1)
25.5 3.1, 31.7 (19.9–32.8) 27.2 2.2, 31.6 (20.5–34.2)
23.4 1.8, 27.0 (19.8–28.7) 25.3, NA (23.9–28.0)†
24.6 1.4, 27.4 (21.9–27.4) 26.8 2.8, 32.4 (21.9–37.0)
25.2 1.9, 29.0 (22.6–29.4) 27.0 2.0, 31.0 (22.6–30.9)
26.0 1.9, 29.8 (23.3–29.4) 28.5 2.0, 32.5 (25.1–33.5)
roup, SD was not calculated and the upper limit of normal was not computed.8
dTable 4. Ascending a
Age (yrs) BSA (
45 1. 1)
1.70– 7)
1.90– 3)
2 0)
45–54 1. 3)
1.70– 0)
1.90– 7)
2 5)
55–64 1. 9)
1.70– 7)
1.90– 1)
2 0)
65 1. 6)
1.70– 0)
1.90– 1)
2 5)
*Values are expressed as m in a g
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205er limits of normal were 41 and 30 mm. The mean
scending and descending thoracic aortic diameters
or females were 31.4  3.2 mm and 22.6  2.2
m, respectively, and the corresponding upper
imits of normal were 37.4 and 27.0. The mean
scending and descending thoracic aortic diameters
or males were 33.5  3.6 mm and 25.1  2.5 mm,
espectively, and the corresponding upper limits of
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206.13  age (years)  1.09 (if male)  0.04  age
if male)  5.80  BSA; the formula for predicting
escending aortic diameter is 7.73  0.11  age
years)  0.41 (if male)  0.02  age (if male) 
.91  BSA. Table 5 shows the ascending and
escending aortic cross-sectional area measure-
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207elationship to previous studies. The mean aortic
iameter and cross-sectional area found in the
urrent study are comparable to the dimensions
reviously reported by CT, MRI, and echocardiog-
aphy studies (Table 6) (1–3,6,7,9–12). Our find-
ngs that aortic dimension relates directly to age
2,3,6,7,9) and BSA confirm previous results (6,7).
nterestingly, we also confirmed that the association
etween BSA and aortic diameter was stronger than
hat between BMI and aortic diameter (6,7).
Regarding the relationship between thoracic aor-
ic dimensions and gender, previous works have
eported that male gender is associated with a larger
ortic diameter (3,6). In our study, however, male
ender was a significant predictor only when inter-
cting with age, such that older men have, on
verage, larger aorta than women of a similar age,
ut the difference is smaller for younger men and
omen (Table 3).
In addition to hypertension, smoking was found to
e an independent predictor only of the descending
ortic diameter. It has been suggested that the etiology
Table 5. Ascending and Descending Aortic Cross-Sectional Area
Age (yrs)
Ascending Aorta (n  2,95
Female Patients
(n  1,147)
M
45 3.9 0.8, 5.5 (2.5–8.3) 3.8
45–54 4.4 0.8, 6.0 (2.49–7.28) 4.3
55–64 4.7 0.9, 6.5 (2.80–7.96) 4.7
65 5.2 0.9, 7.0 (3.08–9.11) 5.1
Total 4.6 0.9, 6.4 (2.49–9.11) 4.4
*Values are expressed as mean 1 SD, upper limit (range).
Table 6. Summary of All Previous Data Regarding Normal Limit
Modality Author (Ref. #) Year
Age
Range (yrs)
Anato
the
MRI Kersting-Sommerhoff
et al. (9)
1987 Young
adults
Pulmon
Mohiaddin et el. (11) 1990 10–60 Pulmon
Echo Roman et al. (7) 1989 20–74 Proxima
Drexler et al. (12) 1990 19–30 2 cm ab
Agmon et al.(6) 2003 Pulmon
CT Guthaner et al. (1) 1979 Pulmon
Aronberg et al. (2) 1984 21–61 Caudal
Hager et al. (3) 2002 17–89 Caudal
“at max
Current study 2008 26–75 Pulmon
Data are provided as reported in the original manuscript (some of the manusc
CT  computed tomography; Echo  echocardiography; MRI  magnetic resonanf thoracic aneurysms differs between the ascending
nd the descending segments and that the pathogen-
sis of aneurysms in the descending thoracic aorta may
ore closely resemble that of the abdominal aorta
neurysms than that of ascending thoracic aneurysms
10). Because smoking has been shown to be the risk
actor most strongly associated with abdominal aortic
neurysms, it is not surprising that the current study
nds that smoking is also associated with larger
escending thoracic aorta diameters (11).
The similarity of the findings of Guthaner et al.
1) and the current study suggests that at the level of
he pulmonary artery, there is reasonable resem-
lance between gated noncontrast CT and non-
ated contrast CT measurements. Though the cur-
ent study was not designed to address this issue,
his observation, if further proven by additional
tudies, might suggest that the normal limits pro-
osed in the current work can be used for contrast
ongated studies too. Gated aorta studies, however,
an provide additional information in the form of
emporal diameter changes during the cardiac cycle.
BSA by Gender and Age (cm2/m2)*
Descending Aorta (n 
Patients
1,805)
Female Patients
(n  736)
5.2 (1.87–6.00) 2.0 0.3, 2.6 (1.34–2.67) 2.1
5.9 (2.09–7.19) 2.2 0.3, 2.8 (1.35–3.20) 2.4
6.5 (2.65–9.65) 2.4 0.4, 3.2 (1.48–3.84) 2.6
6.9 (3.23–8.03) 2.7 0.4, 3.5 (1.78–4.31) 3.0
6.3 (1.87–9.65) 2.4 0.4, 3.2 (1.34–4.31) 2.5
r Thoracic Aortic Dimensions Using Any Modality
al Landmark of
ending Aorta
Ascending Aorta
Dimensions Diameter
or Area/m2 (N)
Descending Aorta
Dimensions Diamete
or Area/m2 (N)
artery level 30 4 mm (20) 24 4 mm (20)
artery level 2.1–4.8 cm2/m2 (70) 1.1–2.8 cm2/m2 (70)
cending aorta 30 4 cm (68 male
patients), 27 4
(67 female patients)
the aortic sinus 3.6 0.5 cm2/m2 (25) 1.9 0.4 cm2/m2 (25)
artery level 33 4 (373) 26 3 (373)
artery level 32 5 mm (15) 25 4 mm (15)
e aortic arch 35 mm (102) 26 mm (102)
e aortic arc
l size”
31 4 mm (70) 25 4 (70)
artery level 33 4 mm, 4.5 0.9
cm2/m2 (2,952)
24 3 mm, 2.4 0.5
cm2/m2 (1,930)
provide only partial data). Diameter is given in millimeters and cross-sectional arfor
2) 1,931)
ale
(n 
Male Patients
(n  1,195)
0.7,  0.3, 2.7 (1.34–3.10)
0.8,  0.4, 3.2 (1.50–3.95)
0.9,  0.4, 3.4 (1.50–4.18)
0.9,  0.5, 4.0 (1.98–5.97)
1.0,  0.5, 3.5 (1.34–5.97)s fo
mic
Asc
r
Comments
ary Adopted also for
CT (10)
ary
l as TEE
ove TEE
ary TEE
ary
to th
to th
ima
ary
ripts ea in square centimeters.
ce imaging; TEE  transesophageal echocardiography.
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208The current study was not designed to provide
rognostic data. However, a previous study (12) has
hown that thoracic aortic dissection and rupture is
elated to aortic diameter and that the annual
omplication rate for ascending thoracic aorta di-
meter below 35 mm (the mean in the current study
s 33 mm) and below 40 mm (the upper limit of
ormal in the current study was 41 mm) was 0%
nd 0.3%, respectively. Following the above-
entioned criteria, we found that only 4% of the
atients in the final analysis group had more than
.3% of annual risk for rupture.
In the current study, we used CT data from a
ow-risk population in a selective manner. Identifica-
ion of clinical parameters that were associated with
ncreasing aortic dimensions allowed exclusion of pa-
ients with these parameters from the final analysis
roup. A final analysis group that more closely repre-
ents a “normal” population was defined, as opposed to
he original unselected asymptomatic population. In
he future, when it is impractical to examine a large
umber of healthy subjects of various ages and both
enders, this statistical approach to selecting a “normal”
atient group may be appropriate to determine normal
imits for anatomic or physiologic measurements.
tudy limitations. We describe herein an approach to
rrive at a “normal” sample from a “nearly normal”
nselected group of patients. The major limitation of
uch an approach, in our opinion, is that if the risk
actor profile of the initial unselected group is signif-
cantly biased away from normal, no amount of
ne-tuning can make the sample “normative” and,
herefore, fewer initial risk factors enable a better
normalization” process. The risk factor profile of our
nitial group is given in Table 1. When we compare
he current study group with the American Heart
ssociation—heart disease and stroke statistics—
007 update data (13) and with the MESA (Multi-
thnic Study of Atherosclerosis) population (14),thoracic aorta throughout life as mea- 1987;317:1098.low-risk factor profile, we see that the current study
roup has a lower risk profile. Therefore, we believe
hat the initial group of the study is suitable for the
hittling down process and the final group represents
truly normal sample.
Several other limitations should also be ad-
ressed. The dataset comprises a patient population
rom a single center. Although our initial unselected
roup consisted of a fairly large number of patients,
wing to the whittling down and stratification
rocess, in a few subgroups, we were not able to
rovide an upper normal limit because of low
ubject count. It is also noted that measurement of
ortic diameters by noncontrast CT in the level of
he pulmonary artery may not be representing the
rue short axis, and to measure the true short axis,
ontrast-enhanced study may be required. Lastly,
ecause different scanners were employed during
he course of this study, there could be some
ariability due to the calibration of the measure-
ent itself. However, given the strict acceptance
riteria applied to our CT scanners, this difference
or aortic measurements is likely to be minimal.
O N C L U S I O N S
ssessment of aortic size is possible from CT scans
btained for CAC measurements. Given the impor-
ance of detecting thoracic aortic aneurysm, consider-
tion should be given to including these measure-
ents as part of the clinical report of the CAC scan.
he nomograms provided by our study could allow
uch a report to include a statement regarding the
elationship of a patient’s measurements to the ex-
ected upper normal for a given patient (15–17).
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